北美无创心输出量监测设备市场预测至 2027 年 - COVID-19 影响和设备区域分析(贴片、手表、探头和导管)、适应症(高血压、冠心病、先天性问题、心肌缺血和梗死、心脏)故障、心律失常等)和最终用户(医院、紧急服务中心、家庭护理等)

Historic Data: 2018-2019   |   Base Year: 2020   |   Forecast Period: 2021-2027


No. of Pages: 123    |    Report Code: TIPRE00022787    |    Category: Life Sciences

North America Non-Invasive Cardiac Output Monitoring Device Market

市场介绍

心输出量 (CO) 的测量在医疗实践中至关重要。过去,肺动脉导管 (PAC) 的侵入性监测是测量 CO 的黄金标准,但近年来,已经开发出许多微创或无创设备来测量 CO。心输出量提供有关组织灌注和氧气输送,可以识别死亡或发病风险较高的患者。

 

市场概述与动态

北美无创心输出量监测设备市场预计将从2020年的95,471,090美元增至2027年的129,912,440美元;预计2020年至2027年复合年增长率为5.1%。市场的增长归因于几个关键驱动因素,例如心血管疾病患病率的增加和老年人口的增加。然而,该设备的高成本阻碍了市场的增长。

近年来,已经开发了许多微创或无创设备来测量心输出量(CO)、这在医疗实践中至关重要。心输出量提供有关组织灌注和氧气输送的信息,并可以识别死亡或发病风险较高的患者。据美国疾病控制与预防中心(CDC)估计,美国每 36 秒就有 1 人死于心血管疾病(CVD)。因此,心血管疾病的日益流行正在推动无创心输出量监测设备的采用。同样,老年人口也容易罹患许多慢性疾病。他们大多患有糖尿病、心脏病、肺病等多种疾病,有的还要接受手术。无创心输出量 (CO) 监测是观察危重患者时使用的重要现代医疗实践之一。根据《世界人口展望:2019 年修订版》的数据,到 2050 年,北美四分之一的人口将达到 65 岁或以上。此外,80 岁及以上的人口数量预计将从 143 人增加三倍。到2050年,老年人口将达到4.26亿。因此,老年人口的增加有利于市场的增长。

 

主要细分市场

根据设备,北美无创心输出量监测设备市场分为贴片、手表、探头和探头;导管。探头和导管细分市场在 2019 年占据最大市场份额。然而,预计手表细分市场在预测期内的复合年增长率最高。

根据迹象,北美无创心输出量监测设备市场细分为高血压、冠心病、先天性问题、心肌缺血和梗塞、心力衰竭、心律失常等。高血压细分市场在 2019 年占据了最大的市场份额。然而,预计心力衰竭细分市场在预测期内的复合年增长率最高。

基于最终用户方面,北美无创心输出量监测设备市场分为医院、紧急服务中心、家庭护理等。 2019 年,医院细分市场占据最大市场份额。然而,预计紧急服务中心细分市场在预测期内的复合年增长率最高。

  ;

主要来源和列出的公司

一些与本北美无创心输出量监测设备市场报告相关的主要和次要来源是美国疾病控制和预防中心 (CDC)、食品和药物管理局 (FDA) 和美国心脏协会 (AHA)。< /span>

 

购买报告的理由

  • 根据北美无创心输出量监测设备市场的详细趋势分析确定潜在投资领域 未来几年。
  • 深入了解推动不同成瘾疗法需求的潜在因素 /span>对支出最高的国家/地区进行细分,并确定每个国家/地区提供的机会。
  • 加强您对需求驱动因素和行业趋势方面的市场的了解以及最新的技术发展等。
  • 确定推动北美无创心输出量监测设备市场的主要渠道, span>提供未来机会的清晰画面,这将有助于分析,从而增加收入。
  • 通过关注不同国家/地区正在进行的项目来引导资源北美无创心输出量监测设备市场

 

北美非侵入性心输出量监测设备市场细分

按设备划分

  • 补丁
  • 手表
  • 探头和amp ;导管

按适应症

  • 高血压
  • 冠状动脉疾病
  • 先天性问题
  • 心肌缺血和梗塞
  • 心力衰竭
  • 心律失常
  • 其他

最终用户

  • 医院
  • < span>紧急服务中心
  • 家庭护理
  • 其他

按国家/地区

  • 美国
  • 加拿大< /li>
  • 墨西哥

公司简介

  • 通用电气公司
  • Koninklijke Philips NV
  • 雅培
  • DELTEX MEDICAL
  • LiDCO
  • CONMED Corporation
  • ImaCor
  • NIMedical
  • 百特国际公司


North America Non-Invasive Cardiac Output Monitoring Device Strategic Insights

Strategic insights for North America Non-Invasive Cardiac Output Monitoring Device involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-non-invasive-cardiac-output-monitoring-device-market-strategic-framework.webp
Get more information on this report

North America Non-Invasive Cardiac Output Monitoring Device Report Scope

Report Attribute Details
Market size in 2020 US$ 95,471.09 thousand
Market Size by 2027 US$ 129,912.44 thousand
Global CAGR (2020 - 2027) 5.1%
Historical Data 2018-2019
Forecast period 2021-2027
Segments Covered By 设备
  • 贴片
  • 手表
  • 探针和导管
By 适应症
  • 高血压
  • 冠心病
  • 先天性疾病
  • 心肌缺血及梗塞
  • 心脏衰竭
  • 心律失常
By 最终用户
  • 医院
  • 急救中心
  • 家庭护理
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • General Electric Company
  • Koninklijke Philips N.V.
  • Abbott
  • DELTEX MEDICAL
  • LiDCO
  • CONMED Corporation
  • ImaCor
  • NIMedical
  • Baxter International Inc.
  • Get more information on this report

    North America Non-Invasive Cardiac Output Monitoring Device Regional Insights

    The regional scope of North America Non-Invasive Cardiac Output Monitoring Device refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-non-invasive-cardiac-output-monitoring-device-market-geography.webp
    Get more information on this report

    The List of Companies - North America Non-Invasive Cardiac Output Monitoring Device Market

    1. General Electric Company
    2. Koninklijke Philips N.V.
    3. Abbott
    4. DELTEX MEDICAL
    5. LiDCO
    6. CONMED Corporation
    7. ImaCor
    8. NIMedical
    9. Baxter International Inc.
    Frequently Asked Questions
    How big is the North America Non-Invasive Cardiac Output Monitoring Device Market?

    The North America Non-Invasive Cardiac Output Monitoring Device Market is valued at US$ 95,471.09 thousand in 2020, it is projected to reach US$ 129,912.44 thousand by 2027.

    What is the CAGR for North America Non-Invasive Cardiac Output Monitoring Device Market by (2020 - 2027)?

    As per our report North America Non-Invasive Cardiac Output Monitoring Device Market, the market size is valued at US$ 95,471.09 thousand in 2020, projecting it to reach US$ 129,912.44 thousand by 2027. This translates to a CAGR of approximately 5.1% during the forecast period.

    What segments are covered in this report?

    The North America Non-Invasive Cardiac Output Monitoring Device Market report typically cover these key segments-

  • 设备 (贴片, 手表, 探针和导管)
  • 适应症 (高血压, 冠心病, 先天性疾病, 心肌缺血及梗塞, 心脏衰竭, 心律失常)
  • 最终用户 (医院, 急救中心, 家庭护理)
  • What is the historic period, base year, and forecast period taken for North America Non-Invasive Cardiac Output Monitoring Device Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Non-Invasive Cardiac Output Monitoring Device Market report:

  • Historic Period : 2018-2019
  • Base Year : 2020
  • Forecast Period : 2021-2027
  • Who are the major players in North America Non-Invasive Cardiac Output Monitoring Device Market?

    The North America Non-Invasive Cardiac Output Monitoring Device Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • General Electric Company
  • Koninklijke Philips N.V.
  • Abbott
  • DELTEX MEDICAL
  • LiDCO
  • CONMED Corporation
  • ImaCor
  • NIMedical
  • Baxter International Inc.
  • Who should buy this report?

    The North America Non-Invasive Cardiac Output Monitoring Device Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Non-Invasive Cardiac Output Monitoring Device Market value chain can benefit from the information contained in a comprehensive market report.